Primary Record
GSK3145095
- In stock
- 6,820 g
- Purity
- 99.6 %
- CAS
- 1622849-43-7
Compound Identifiers & Properties
- CAS
- 1622849-43-7
- PubChem CID
- 118557502
- SMILES
- C1CC2=C(C(=CC(=C2)F)F)NC(=O)[C@H]1NC(=O)C3=NNC(=N3)CC4=CC=CC=C4
- Canonical SMILES
- O=C(N[C@H]1CCc2cc(F)cc(F)c2NC1=O)c1n[nH]c(Cc2ccccc2)n1
Names & Synonyms
- GSK3145095
- 1622849-43-7
- UNII-B4D3WPS7JY
- B4D3WPS7JY
- RefChem:201114
- CHEMBL4452233
- GSK-3145095
- orb1308246
- SCHEMBL17312826
- SCHEMBL25294190
- SCHEMBL25798915
- GTPL12245
- GSK 3145095
- GSK'095
- RIPK1 inhibitor GS3145095
- C20H17F2N5O2
- GLXC-21150
- RIPK1 Inhibitor GSK3145095
- BCP31015
- compound 6 [PMID: 31223438]
- EX-A3069
- XPC84943
- BDBM50502339
- MFCD32062741
- s8845
- AKOS040741817
- AT16390
- compound 6 (PMID: 31223438)
- GSK3145095?
- AC-36366
- DA-77476
- MS-26701
- 5-benzyl-N-[(3S)-7,9-difluoro-2-oxo-1,3,4,5-tetrahydro-1-benzazepin-3-yl]-1H-1,2,4-triazole-3-carboxamide
- HY-111946
- CS-0094287
- GSK-3145095; GSK 3145095
- A1001925
- (S)-5-benzyl-N-(7,9-difluoro-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-3-yl)-4H-1,2,4-triazole-3-carboxamide
- (S)-5-Benzyl-N-(7,9-difluoro-2-oxo-2,3,4,5-tetrahydro-1hbenzo(b)azepin-3-yl)-1H-1,2,4-triazole-3-carboxamide (7,7-dimethyl-2- oxobicyclo(2.2.1)heptan-1-yl)
- Receptor-interacting Serine/Threonine-protein Kinase 1 Inhibitor GSK3145095
- (S)-5-BENZYL-N-(7,9-DIFLUORO-2-OXO-2,3,4,5-TETRAHYDRO-1HBENZO(B)AZEPIN-3-YL)-1H-1,2,4-TRIAZOLE-3-CARBOXAMIDE (7,7-DIMETHYL-2-OXOBICYCLO(2.2.1)HEPTAN-1-YL)
- ~{N}-[(3~{S})-7,9-bis(fluoranyl)-2-oxidanylidene-1,3,4,5-tetrahydro-1-benzazepin-3-yl]-3-(phenylmethyl)-1~{H}-1,2,4-triazole-5-carboxamide
- 5-benzyl-N-((3S)-7,9-difluoro-2-oxo-1,3,4,5-tetrahydro-1-benzazepin-3-yl)-1H-1,2,4-triazole-3-carboxamide
- 5-benzyl-N-[(3S)-7,9-difluoro-2-oxo-1,3,4,5-tetrahydro-1-benzazepin-3-yl]-2H-1,2,4-triazole-3-carboxamide